Biocompatible nanoparticles attract the attention of researchers as a means of correcting a wide range of diseases. The carbonbased nanostructure, fullerene C60, is one of the most promising compounds. However, the use of compounds based on fullerene nanoparticles remains limited. Therefore, the development of domestic innovative medicinal compounds based on fullerenecontaining nanoparticles is one of the priority areas of veterinary medicine. The research was carried out in the laboratory of the Department of "Morphology, Pathology of Animals and Biology" of the Saratov State Agrarian University named after N.I. Vavilov. The first group served as a control. An aqueous solution of fullerene C60 was administered at a dose of 1 ml per (DV 5 mg / kg) 1 kg of body weight (group 2 animals). A compound based on an aqueous solution of fullerene C60 was also introduced, including an aqueous solution of fullerene C60, Lcarnosine and succinic acid in the following ratio of components, wt. / mg: an aqueous solution of fullerene C60 stabilized with pluronic F-127– - 5 ml (5 mg by DV), Lcarnosine -50 mg, succinic acid - 50 mg per 1 kg of body weight (group 3). The studied compounds were administered intramuscularly, once. Glycerin loading was carried out 24 hours after the introduction of the studied compounds. It was found that aqueous solutions of fullerene C60 have a distinct effect on carbohydrate metabolism in the body of white rats. The initial blood glucose level in animals of all groups turned out to be approximately at the same level, but the highest rate of gluconeogenesis was found in animals of group 2. As for the gluconeogenic function of the liver, in animals after the introduction of aqueous solutions of fullerene C60, the increase in newly formed glucose and the rate of gluconeogenesis significantly exceeded the control values. The results obtained indicate a failure in glucose metabolism after the introduction of aqueous solutions of fullerenes.